INHIBRX BIOSCIENCES, INC.
11025 N. Torrey Pines Road, Suite 140
La Jolla, CA 92037
May 22, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jimmy McNamara and Suzanne Hayes
| Re: | Inhibrx Biosciences, Inc. Form 10-12B File No. 001-42031 |
Dear Mr. McNamara and Ms. Hayes:
In accordance with Rule 12d1-2 promulgated under the Securities Exchange Act of 1934, as amended, Inhibrx Biosciences, Inc. hereby respectfully requests that the effective date of its Registration Statement on Form 10 (File No. 001-42031) (the “Registration Statement”) be accelerated by the Securities and Exchange Commission to 3:00 p.m., New York City time, on May 24, 2024, or as soon thereafter as practicable.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Brian M. Janson at (212) 373-3588, with written confirmation sent to the address listed on the cover of the Registration Statement to follow.
| Sincerely, | |||
| INHIBRX BIOSCIENCES, INC. | |||
| By: | /s/ Kelly Deck | ||
| Name: | Kelly Deck | ||
| Title: | Chief Financial Officer | ||